Belvedere Trading LLC Immuno Gen, Inc. Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$12.46 - $29.95 $54,014 - $129,833
-4,335 Reduced 25.5%
12,662 $375,000
Q3 2023

Oct 27, 2023
SELL
$14.09 - $19.87 $40,311 - $56,848
-2,861 Reduced 14.41%
16,997 $269,000
Q2 2023

Aug 08, 2023
BUY
$3.75 - $20.05 $36,840 - $196,971
9,824 Added 97.91%
19,858 $374,000
Q1 2023

May 15, 2023
BUY
$3.67 - $4.92 $36,824 - $49,367
10,034 New
10,034 $38,000

Others Institutions Holding IMGN

# of Institutions
8
Shares Held
1.41M
Call Options Held
0
Put Options Held
0
View Full List

About ImmunoGen, Inc.

IMGN Quotes by TradingView
  • Ticker IMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 220,712,992
  • Description
  • ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...
More about IMGN
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email